Sarntinoranont, Malisa, Michael J. Iadarola, Russell R. Lonser, and Paul F. Morrison. Direct interstitial infusion of NK1-targeted neurotoxin into the spinal cord: a computational model. Am J Physiol Regul Integr Comp Physiol 285: R243-R254, 2003; 10.1152 10. /ajpregu.00472.2002-enhanced delivery of substance P (SP) nocitoxins to the spinal cord interstitium is under consideration for the treatment of chronic pain. To characterize treatment protocols, a three-dimensional finite-element model of infusion into the human dorsal column was developed to predict the distribution of SP-diphtheria toxin fusion protein (SP-DTЈ) within normal and target tissue. The model incorporated anisotropic convective and diffusive transport through the interstitial space, hydrolysis by peptidases, and intracellular trafficking. For constant SP-DTЈ infusion (0.1 l/min), the distribution of cytotoxicity in NK1 receptor-expressing neurons was predicted to reach an asymptotic limit at 6-8 h in the transverse direction at the level of the infusion cannula tip (ϳ60% ablation of target neurons in lamina I/II). Computations revealed that SP-DTЈ treatment was favored by a stable SP analog (half-life ϳ60 min), high infusate concentration (385 nM), and careful catheter placement (adjacent to target lamina I/II). Sensitivity of cytotoxic regions to NK1 receptor density and white matter protease activity was also established. These data suggest that intraparenchymal infusions can be useful for treatment of localized chronic pain. convection-enhanced delivery; intraparenchymal infusions; pain therapy; pharmacodynamic model; convection; finiteelement method INVESTIGATORS INTERESTED in treating persistent pain conditions have taken advantage of the substance P (SP)-mediated endocytotic pathway, using it as a transport system to deliver cytotoxic fusion proteins to neurokinin type 1 receptor (NK 1 R)-expressing neurons located within the dorsal horn of the spinal cord. SPsaporin toxin, SP-diphtheria toxin (SP-DTЈ), and SPPseudomonas exotoxin conjugates have been identified as capable of selectively lesioning second-order spinal cord neurons, thereby blocking nociceptive transmission mediated by small-diameter A␦ and C fibers and, possibly, A␤ fibers (5, 15, 28, 35, 52) . In this study, we investigate the transport and drug delivery of SP-DTЈ (ϳ47,000 mol wt), a COOH-terminal truncated diphtheria toxin that retains the transmembrane and catalytic domains of diphtheria toxin but replaces the native binding domain with SP (15) 
INVESTIGATORS INTERESTED in treating persistent pain conditions have taken advantage of the substance P (SP)-mediated endocytotic pathway, using it as a transport system to deliver cytotoxic fusion proteins to neurokinin type 1 receptor (NK 1 R)-expressing neurons located within the dorsal horn of the spinal cord. SPsaporin toxin, SP-diphtheria toxin (SP-DTЈ), and SPPseudomonas exotoxin conjugates have been identified as capable of selectively lesioning second-order spinal cord neurons, thereby blocking nociceptive transmission mediated by small-diameter A␦ and C fibers and, possibly, A␤ fibers (5, 15, 28, 35, 52) . In this study, we investigate the transport and drug delivery of SP-DTЈ (ϳ47,000 mol wt), a COOH-terminal truncated diphtheria toxin that retains the transmembrane and catalytic domains of diphtheria toxin but replaces the native binding domain with SP (15) or an analog of SP [(pGlu 5 ,MePhe 8 , MeGly 9 )-substance P-(5-11) (DiMeC7)] stabilized against peptidase activity (14) .
Previous animal studies investigating NK 1 R-targeted neurotoxins have used intrathecal delivery to circumvent the blood-brain barrier. In the rat, intrathecal infusion of these compounds has been shown to significantly reduce hyperalgesia (5, 28 ). However, a major challenge remains in achieving this effect at the larger scale of primates and humans. In these species, the principal cell targets, laminae I and II of the dorsal horn, lie deeper in the spinal cord and are not in direct contact with the intrathecal cerebrospinal fluid (CSF), as in the rat. Consequently, the neurotoxins must traverse a much greater distance within the primate or human spinal cord tissue and, given the slow rate of macromolecular diffusion in tissue (43) , be substantially more exposed to the degradative action of endogenous peptidases. As a result, these therapeutic molecules are unlikely to reach their target cells in sufficient concentration to be efficacious, and the need for a different mode of drug delivery is indicated. In addition, intrathecal infusion results in bilateral treatment. However, many conditions are localized, and, in such cases, a more discrete application would be therapeutically advantageous.
An alternative to intrathecal delivery is direct interstitial infusion or convection-enhanced delivery (CED) (7, 25, 32) . By this method, an agent is infused directly into the nervous tissue via a cannula and is transported through the interstitial space primarily by convection, or bulk flow, allowing for greater volume transmission and control over exposure (7, 24, 25, 32) . To anticipate the tissue distribution of administered agents by infusion into the central nervous system (CNS), mathematical models of CED have been developed. Early models accounted for the distribution into gray matter regions of the brain, characterized by isotropic transport and mechanical properties (3, 4, 32) . More recently, a three-dimensional image-based finite-element model of CED into the spinal cord has been developed (44) that captures transport in gray and anisotropic white matter regions and accounts for the distribution of albumin observed in rat spinal cord.
Interstitial transport is anisotropic within white matter (7, 41, 42) because of preferential diffusion and fluid flow in the interstitial space parallel to axonal fibers. Taking advantage of this low-resistance pathway, Lonser et al. (26) and Wood and colleagues (54) showed that direct infusion into the white matter dorsal column provides a basis for safe distribution of macromolecules over significant volumes of the spinal cord. In the present study, we extend the anisotropic CED model (44) to describe SP-DTЈ transport when the toxin is infused into the white matter dorsal column of the human spinal cord. The objective of an effective chronic pain therapy is to reach nociceptive neurons located in laminae I, II, and X in concentrations adequate to induce cytotoxicity while, at the same time, avoiding the destruction of anterior motor neurons or other cells within the spinal cord that express the NK 1 R (1, 6). To address these constraints, the model incorporated primary transport considerations, including regional anatomic boundaries, interstitial fluid flow, enzymatic degradation, and binding of SP-DTЈ to target neurons. Ultimately, cytosolic diphtheria toxin blocks cellular protein synthesis and kills the cell. By coupling intracellular trafficking kinetics (45) to the model, cytosolic concentrations of toxin were determined which provided a basis for predicting regions of cell death.
METHODS
Spinal cord geometry. The spinal cord geometry was created from a single transverse section of the spinal cord at the C 7 level, on which white and gray matter regions, including the different lamina, were outlined (Fig. 1 ). Visualization and finite-element meshing programs (Amira, version 2.3, TGS, San Diego, CA; Gambit, version 1.3, Fluent, Lebanon, NH) were used to project the segmented outlines 20 mm in the craniocaudal (z) direction, creating separate white and gray matter volumes. [Craniocaudal variation in the projected area (between C 6 and C8) was neglected. Also, greater projection lengths had no significant effect on fluid flow distribution.] A spherical infusion site (radius ϭ 0.306 mm) was incorporated into the white matter dorsal column (x ϭ 0, y ϭ 0, z ϭ 0). The epicenter of the site was 0.45 mm lateral to the dorsal median fissure, 2.14 mm posterior to lamina X, and 2.10 mm anterior to the external surface of the spinal cord. Reflection symmetry about the transverse plane through the infusion site was assumed. Overall dimensions of the final spinal cord geometry (Fig. 1 ) are as follows: craniocaudal, 20.0 mm (40.0 mm with symmetry); mediolateral, 10.9 mm; and dorsoventral, 6.54 mm. In computations examining the sensitivity of distribution to infusion site location, secondary locations were considered in which the infusion site was shifted 0.8 mm laterally toward lamina I and 1.6 mm anteriorly toward lamina X.
Interstitial fluid flow. To describe fluid flow in the spinal cord, the tissue was treated as a porous medium composed of an interstitial volume phase through which bulk flow occurs and a noninterstitial "solid" phase composed of intercellular matrix, cells, white matter fibers, and blood vessels. Fluid and solute transport through porous media is described by a continuum model accounting for differential mass and momentum balances. For steady-state flow conditions, conservation of fluid mass is expressed by the continuity relation
where ٌ⅐ is the divergence operator and u is the volumeaveraged fluid velocity. The contribution of fluid sources and sinks would require the inclusion of additional pressuredependent terms proportional to the difference in interstitial and capillary pressure. However, such terms were neglected in this model, because tissues of the CNS are devoid of an active lymphatic system (9), characterized by low rates of fluid transfer across the capillary walls at the pressures encountered during interstitial infusion at a moderate flow rate (32), subject to negligibly low rates of water formation by metabolism (22) , and because only isotonic solutions of SP-DTЈ were considered. The momentum equation is expressed by Darcy's law
where is the hydraulic conductivity tensor, ٌ is the gradient operator, and p is the interstitial fluid pressure. is a measure of the conductance of the material to fluid flow and is dependent on pore geometry and the structure of the interstitial matrix. is isotropic in gray matter (12, 25) but highly anisotropic in white matter because of the presence of the aligned nerve fibers (7, 26) . White matter hydraulic anisotropy is quantified by large values of wm-z/wm-x, which is the ratio of the hydraulic conductivity of white matter in the craniocaudal direction, parallel to the aligned fibers, to the hydraulic conductivity of white matter in the transverse direction (Table 1) . The model was limited to a description of flow through a rigid porous medium. Only low volumetric flow rates were considered, and elastic expansion effects were accounted for by increasing the interstitial volume fraction () from the normal value of 0.20 to 0.26 (12, 40, 44) . In the present study, and were derived from data specific for an infusion rate of 0.1 l/min (26, 44, 54) . Boundary conditions were such that a volumetric infusion rate of 0.1 l/min was applied at the infusion site boundary, and zero fluid pressure conditions were applied at the external spinal cord-CSF boundaries. Along the symmetrical plane (z ϭ 0), symmetry boundary conditions were assumed: u ⅐ n ϭ 0, where n is the unit normal vector to the surface. At the far end of the tissue (z ϭ (18) were used to develop a simple kinetic model (Fig. 2) of SP binding and intracellular trafficking (45) . This kinetic model incorporates the principal trafficking steps, including surface binding between SP and NK 1R, clathrin-mediated endocytosis followed by spatial translation to a perinuclear endosome, where SP is sorted from its receptor, rapid degradation of SP once sorted to the late endosomes/early lysosomes, and return of sorted receptor to plasma membrane via recycling endosomes. In addition, the model follows previous research allowing for a very low rate of transfer of the diphtheria toxin moiety from early sorting endosomes to cytosol (57) . Incorporation of this trafficking model into the present model allowed for estimation of the cytosolic diphtheria toxin concentration, which is ultimately responsible for cell kill.
Transport equations were derived by applying mass conservation to SP-DTЈ and the NK 1R in their various compartments: SPe (SP-DTЈ in the extracellular space), B (bound SP-DTЈ on the cell surface), R (free NK1R on the cell surface), SPs (early/sorting endosomal SP-DTЈ), Rs (NK1R in early/ sorting endosomes), Rpost (NK1R in recycling endosomes), and Ccyt (SP-DTЈ/diphtheria toxin in cytosol). The relation governing interstitial transport of SPe is (all concentrations expressed on a tissue averaged basis)
where t is time and D is the effective diffusivity tensor of the interstitium and is the interstitial volume fraction. Other constants are k m (rate of degradation by peptidases) and k1 and k2 (rates of SP-DTЈ association and dissociation from the receptor). 
and
Intracellular trafficking constants are as follows: ki (rate of SP-DTЈ internalization), ktrans (rate of SP-DTЈ transfer from endosome to cytosol), ks (rate of SP-DTЈ and NK1R intracellular sorting), and krcyc (rate of NK1R transfer from the recycling endosomes to the cell surface). Because NK1R are conserved
where Bmax is the NK1R capacity and varies within different laminae of the spinal cord.
To determine the temporal and spatial distribution of the SP-DTЈ complex, Eqs. 1-10 were solved over the spinal cord volume. For the initial condition before infusion, concentration of membrane-bound NK 1R (R) was set equal to the corresponding Bmax. All other concentrations were initially zero. Concentration of SPe at the infusion site boundary was set equal to Cinf where is the tissue porosity and Cinf is the infusate concentration, a constant value (77, 385, and 770 Fig. 2 . Schematic of substance P (SP) trafficking model. SPЈ, partially degraded SP-diphtheria toxin (SP-DTЈ) peptide pool; km, rate of degradation by peptidases; k1 and k2, rates of association and dissociation, respectively, of the receptor; ki, rate of SP-DTЈ internalization; ktrans, rate of SP-DTЈ transfer from endosome to cytosol; ks, rate of SP-DTЈ and neurokinin type 1 receptor (NK1R) intracellular sorting; krcyc, rate of NK1R transfer from recycling endosomes to cell surface. nM). Transport of SPe across the external spinal cord/CSF surfaces was assumed to be dominated by convection, with negligible loss due to diffusion (ϪDٌSP e ⅐ n ϭ 0). Along the symmetrical plane (z ϭ 0), SPe flux normal to the surface was set to zero (ٌSPe ⅐ n ϭ 0).
Parameter values. Parameters are tabulated in Tables 1  and 2 . Tissue porosity and hydraulic conductivity values for gray and white matter were taken from a previous analysis of albumin infusion in the rat cord (44) . Effective diffusivity in gray matter (D gm) was taken from measures of a similarmolecular-weight protein (i.e., albumin, ϳ66,000 mol wt) in brain tissue (48) , and the tensor components of the effective diffusivity in white matter (D wm-x, Dwm-y, and Dwm-z) were estimated from measurements of anisotropic diffusion in the spinal cord (41) . Rate constants k 1, k2, ki, ks, and krcyc were taken from previous analysis (45) (8), and Grady et al. (18) . The gray matter degradation rate (k m-gm) was set equivalent to an SP half-life of 60 min (14) . Some sensitivity studies were also performed using an SP gray matter half-life of 3 min. SP e degradation rate in white matter interstitium was bracketed by setting it equal to the CSF degradation rate (23) or to one-half of the gray matter rate. The latter is a high-end estimate that accounts for the absence of enkephalinase activity in white matter (39) but allows for degradation by peptidases that have not been quantitatively characterized (11) . Receptor capacities (B max) ranged from zero in the white matter, where no NK1R are detectable (13) , to tissue-averaged concentration values of 23 nM, reflective of the receptor densities in laminae I, II, and X (1). Sensitivity to changes in receptor capacity was also analyzed.
Diphtheria toxin cytotoxicity analysis is dependent on the rate of transfer of toxin from the endosome to cytosol, as determined by k trans. Although this parameter has not been determined specifically for SP-DTЈ, it is known to depend heavily on the toxic moiety and is independent of the cell line involved (57) . Accordingly, the value of k trans in our target neurons has been roughly approximated by the 3.5 ϫ 10 Ϫ5 min Ϫ1 value measured previously for diphtheria toxin conjugated to transferrin (57) . (Sensitivity computations show that substantial uncertainty can be tolerated in this parameter, because the steep leading edge of the C cyt profiles renders the cytotoxic contours insensitive to nearly order-ofmagnitude uncertainties in the cytosolic concentrations of the diphtheria toxin moiety.)
Cytotoxic response. Approximate contours of cytotoxicity were predicted by locating the tissue regions where NK 1R-expressing cells contained Ն10 molecules of the diphtheria toxin moiety in the cytosol. This threshold number exceeds the single-molecule value reported by Yamaizumi et al. (55) as sufficient for a diphtheria toxin fragment A to kill a cell. However, this threshold is consistent with the number of molecules required to fully deplete the elongation factor 2 (EF2) pool when the fragment's half-life is taken as 16 h (47), rather than several days, as reported earlier (33, 56) . {The number of toxin molecules required for depletion of the EF2 pool [N(t)] was computed from a model of the following form:
, where N and [EF2] are the number of toxin and EF2 molecules per cell, N decays exponentially from its initial loading value N 0 with a 16-h half-life, EF2(0) Ϸ 2.1 ϫ 10 6 molecules/cell (56) , and k ϭ 0.001 min Ϫ1 , corresponding to a toxin destruction rate of 2,000 EF2 molecules per toxin molecule per cell per minute (33) . N 0 is the minimal value allowing [EF2] Ͻ 1 as t 3 ϱ.} The threshold cytosolic concentration for a neuron was thus 10 toxin molecules per neuronal cell volume of 10.8 pl (37) or 1.5 pM. Because spinal cord distributions were computed on a tissueaveraged basis and because this threshold is approached only in SP receptor-bearing neurons, 1.5 pM was converted to a tissue-averaged threshold value (Ccyt thres) according to Ccyt thres ϭ 1.5 pM ϫ (fraction neuronal volume) ϫ (fraction of NK1R-positive neurons). The fractional neuronal volume is ϳ0. 17 (31) ; the fraction of NK1R-positive neurons varies by lamina, with the assumption of the following values: 0.45, 0.29, and 0.18 in laminae I, IV-VI, and X and 0.11 in lamina II/III (49) . For lamina I, the primary drug target, Ccyt thres ϭ 0.12 pM. Lower values apply to the other laminae in accordance with their reduced NK1R expression, but the cytotoxic contours computed for these laminae differ little from those computed using the 0.12 pM lamina I threshold because of the leading-edge steepness of the Ccyt concentration profiles.
Implementing the finite-element method. The equations were solved by a Galerkin finite-element method (FIDAP version 8.60, Fluent, Lebanon, NH) using an iterative segregated approach. Transient solutions were calculated with an implicit time integration scheme (2nd-order trapezoid rule) in conjunction with an adaptive time-stepping methodology. The spinal cord model was discretized into finite elements with the use of eight nodal hexahedral elements. The final mesh for the full three-dimensional model consisted of 1.5 ϫ 10 6 elements. (Meshes with alternate infusion sites had similar element counts.) With consideration that the steadystate velocity field was quickly established and that the presence of infusate solute did not affect the fluid flow solution, a weakly coupled problem was assumed. Thus the solution for the steady-state velocity and pressure (Eqs. 1 and 2) was obtained, first, using the full three-dimensional geometry (⌬z ϭ 20.0 mm). Concentration distributions of the nonfluid components were then computed from their mass balances (Eqs. 3-10) while the fluid velocity values were fixed at their steady-state values. Because of prohibitively long calculation times required for the 1.5 ϫ 10 6 element mesh, concentrations were determined using a truncated mesh representing a thin transverse section at the site of infusion (⌬z ϭ 0.1 mm, 65,000 elements), at which level maximum penetration of SP-DTЈ occurs.
The convergence criterion for velocity and pressure was 10 Ϫ7 , and the concentration convergence criterion was 10 Ϫ6 . SP-DTЈ, substance P-diphtheria toxin; NK1R, neurokinin 1 receptor; k1 and k2, rates of association and dissociation, respectively, of receptor; krcyc, rate of NK1R transfer from recycling endosomes to cell surface; ki, rate of SP-DTЈ internalization; ks, rate of SP-DTЈ and NK1R extracellular sorting; km-gm and km-wm, rate of degradation by peptidases in gray and white matter, respectively; ktrans, rate of SP-DTЈ transfer from endosome to cytosol; Bmax, NK1R capacity. * Based on fits to a kinetic model (45) . † Tissue-averaged basis.
‡ Approximated values.
Reduction of these criteria by two orders of magnitude did not affect results (negligible change). Mesh independence was assessed by increasing the number of elements by 30%. The resulting changes in C cyt distribution after 2 and 8 h of SP-DTЈ infusion were negligible. Computations were conducted on a personal computer workstation (Dell Precision 620) with dual Pentium III 1.0-GHz processors and 2.0 GB of random access memory. For calculation of an 8-h infusion, ϳ16 h were required for steady-state velocity and pressure simulations and ϳ32 h for albumin transport simulations.
RESULTS
Interstitial fluid flow field. Consistent with a previous simulation study of the rat spinal cord conducted at the same volumetric flow rate of 0.1 l/min (44), interstitial fluid flow within the human spinal cord was predicted to be greatest in the white matter in the craniocaudal direction, parallel with the aligned fibers. Fluid flow was also predicted to skew laterally toward the white matter-CSF boundary. Interstitial fluid velocity dropped rapidly with distance from the infusion site, as presented in Fig. 3 , which shows the calculated u x decreasing with increasing distance from the infusion site along an x-directed line (Fig. 4) . Because of the lower tissue permeability of gray matter, the bulk fluid flow within the gray matter regions was limited (the mean volume-averaged interstitial flow rate within a 0.1-mm-thick slice at the level of the cannula tip was calculated to be 2.5 ϫ 10 Ϫ8 cm/s in lamina I/II). To study the effect of the zero pressure boundary condition at the far end of the cord, pressure and velocity were solved for ⌬z ϭ 20 and 40 mm spinal cord lengths. These interstitial velocity solutions were used to solve for the distribution of a nonreactive, nonbinding macromolecule, i.e., albumin (ϳ66,000 mol wt). Resulting simulations showed negligible difference in craniocaudal distribution of albumin, even after 8 h of infusion at 0.1 l/min. The computed craniocaudal distributions of albumin corresponding to 10-, 20-, and 30-l infusions (1.7, 3.3, and 5 h) were 1.4, 1.8, and 2.2 cm, respectively (using a 0.15C inj plotting threshold value and midline cannula placement adjacent to lamina X). When these results are compared with previous magnetic resonance imaging (MRI) measurements of gadoliniumlabeled albumin infused into the lateral column of primates (26) , simulation results correspond well to MRI measures for infusions up to ϳ4.2 h (25 l or ϳ1.6 cm of craniocaudal spread).
Extracellular SP-DTЈ. With initial infusion, extracellular SP-DTЈ was transported through the white matter interstitium by bulk flow while subject to relatively low enzymatic degradation, allowing large regions of the dorsal column to be exposed. The extracellular spread of SP-DTЈ in the transverse plane containing the cannula tip during 12 h of continuous infusion of 385 nM is presented in Fig. 5 , where contours are drawn at SP-DTЈ concentrations that are 15% of the tissue concentration immediately adjacent to the cannula tip (i.e., 0.15C inj plotting threshold). At the times shown, SP e is confined primarily to the white matter interstitium, and asymmetry in the distribution was due to the off-center infusion site. The extent of white matter spread depended on the level of peptidase activity. For very little activity, equivalent to the degradation rate in the CSF (23), the entire extracellular space of the dorsal column at the level of the cannula tip was filled after 12 h of infusion of 385 nM SP-DTЈ at 0.1 l/min (Fig. 5A ). For white matter activity equal to one-half of the gray matter rate, the maximum spread did not fill the dorsal column, and spread reached an effective penetration limit after 8 h of infusion under the same conditions (Fig. 5B) . As SP-DTЈ entered the gray matter regions, it was subject to receptor uptake and degradation, and interstitial convective transport was greatly reduced. An SP e concentration profile through a section of the target tissue, lamina I/II, at the level of the cannula tip is shown in Fig. 6 (8 h of infusion of 385 nM SP-DTЈ at 0.1 l/min and white matter peptidase activity of Fig. 5A ). Here, SP e dropped below the 15% plotting threshold (15 nM, tissue-averaged value) within 0.01 cm of the gray matter-white matter interface.
Intracellular SP-DTЈ. Simultaneously, concentrations of B, R, SP s , R s , and R post within NK 1 R-expressing neurons were also determined, and the cross-sectional profiles of these tissue-averaged concentrations through lamina I/II at the level of the cannula tip are presented in Fig. 6 after 8 h of infusion of 385 nM SP-DTЈ at 0.1 l/min. As SP-DTЈ (SP e ) enters the laminar region, it binds strongly to cell surface NK 1 Rs, first to those initially present on the cell surface and then just to those recycled to the surface. This eventually allows the rate of NK 1 R internalization to balance the recycling rate over the first 0.035 cm from the gray matter-white matter interface, leading to the steady concentrations of surface-bound and endosome-borne NK 1 R pools (B, R s , and R post ), as well as SP s (Fig. 6) . Exposed NK 1 R-expressing neurons extend through nearly 60% of the target lamina I/II at the level of the cannula tip. In unexposed regions, B, SP s , R s , and R post are zero, and the concentration of free receptors on the cell surface (R) equals B max . Cytosol concentrations of SP-DTЈ were also tracked. Because of the low endosomal escape rate (k trans ), these concentrations were orders of magnitude smaller than those of the other cellular compartments (Fig. 7) . Higher concentrations of C cyt in lamina I/II and X tissue reflect the higher NK 1 R densities and, thus, greater cellular uptake in these regions.
Cytotoxic regions. A cytosolic toxicity threshold of 0.12 pM was applied to predict spinal cord regions in which NK 1 R-expressing neurons would be selectively ablated. The advancement of these cytotoxic regions in the transverse plane of the infusion source is presented in Fig. 8 . Unless otherwise noted, the interstitial white matter degradation rate of SP-DTЈ in these simulations was set equal to the CSF degradation rate (23) . The initial phase of infusion caused SP-DTЈ to traverse the intermediate white matter regions, and continued infusion allowed SP-DTЈ to penetrate farther into the Ϫ1 ] or at a rate equal to one-half that in gray matter (B; km-wm ϭ 0.00578 min Ϫ1 ). Contours describe location over time of SPe concentration equal to 15% of concentration at infusion site (0.15Cinj, where is interstitial volume fraction and Cinj is infusate concentration). gray matter regions adjacent to the dorsal column. For the protocol shown in Fig. 8 (385 nM SP-DTЈ with approximately central cannula placement), ϳ33 min (3.3 l) of SP-DTЈ infusion was required for NK 1 Rexpressing neurons at the nearest lamina to begin reaching cytotoxic levels. With continued infusion, cytotoxicity was predicted to extend across Ͼ60% or 0.43 mm of lamina I/II (along the cut closest to the infusion site, Figs. 4 and 6 ) and across the majority of the lamina X band. The predicted penetration into laminae I, II, and X, despite the presence of high concentrations of NK 1 R in these regions, was not markedly different from penetration into the neighboring laminae. The rate of transverse laminar cytotoxic penetration began to slow after 6 h of infusion, and prolongation of the infusion for an additional 6 h increased the penetration by only 3% along the same lamina I/II cut. Thus predicted regions of cytotoxicity reached an effective penetration limit in the transverse direction. At the level of the cannula tip, this limit was calculated to be 6-8 h (36-48 l) for the 0.1 l/min infusion protocols of this study. At the same time, anterior regions of the spinal cord were unaffected.
Continued SP-DTЈ spread after termination of the interstitial infusion was also analyzed. At 24 h after the baseline 8-h infusion, simulations showed that cytotoxic regions in the transverse plane containing the cannula tip did not change, except in a small region of the substantia gelatinosa on the side most distant from the infusion site (not shown). With shorter infusion periods, predicted cytotoxic regions continued to expand in this same transverse plane after the end of infusion. At 24 h after a 4-h infusion, cytotoxic spread along the lamina I/II cut closest to the infusion site increased by 9% compared with the penetration distance calculated immediately after the end of infusion (Fig. 9) .
Sensitivity of the cytotoxicity zones to changes in infusion protocol was also investigated (Fig. 10) . The base case for these computations was cytotoxic response for an infusate concentration of 385 nM, a volumetric infusion rate of 0.1 l/min over 8 h, degradation rate in gray matter (k m-gm ) ϭ 0.0116 min
Ϫ1
(half-life ϭ 60 min), penetration rate into white matter (k m-wm ) ϭ 0.000052 min Ϫ1 (half-life ϭ 9 days), and a central cannula tip location as depicted in Fig. 8 .
First, increasing or decreasing the infusate concentration from 385 nM to 77 or 770 nM SP-DTЈ resulted in a corresponding nonlinear increase or decrease in transverse cytotoxic penetration (Fig. 10A) . Increasing the concentration to 770 nM increased the penetration along the closest lamina I/II cut by 40%. Penetration to the ventral side of lamina X was also predicted, but it was not associated with significant exposure of the anterior motor regions.
Second, movement of the infusion site to locations more proximate to the target regions was predicted to have a significant effect. Placement of the cannula tip closer to lamina I/II (⌬x ϭ 0.8 mm) resulted in a 44% increase in cytotoxic penetration along the closest lamina I/II cut relative to that for the baseline infusion location (Fig. 10B) . Furthermore, cytotoxic penetration into lamina I/II on the opposite side was reduced. After the cannula was positioned closer to lamina X (⌬y ϭ 1.6 mm), SP-DTЈ was predicted to cross lamina X and reach the motor neurons in the ventral horn via the white matter of the ventral column.
Third, use of an SP analog that is resistant to peptidase action provided for a much deeper predicted penetration into the laminae than is achieved with nonstabilized SP. Peptidase activity against neuropeptides is greater in gray than in white matter and, in the case of enkephalinase, nearly undetectable in white matter by immunoautoradiography (39) . Accordingly, we determined the advantage of using stabilized SP moieties by contrasting the cytotoxicity penetration depth achieved with such an analog (characteristic peptidase degradation time of 60 min in gray matter, base case) to that achieved by nearly normal SP (characteristic degradation time of 3 min), while maintaining white matter activity at the minimal level typical of degradation in the CSF (23) . At the higher gray matter degradation rate, the penetration of cytotoxicity along ). Lines correspond to cytotoxic border for 1-and 2-h intervals. Cytotoxicity was based on Ccytthres of 0.12 pM.
the lamina I/II cut closest to the cannula tip was predicted to decrease by 40% (Fig. 10C) . Because peptidases other than enkephalinase are known to be active against SP in spinal cord slices (11), the possibility exists that white matter activity may be higher than the CSF activity used in our base case. A second simulation was thus performed to determine the effect of white matter peptidase activity on the extent of cytotoxicity. White matter activity was taken at an estimated upper-bound limit of one-half of the gray matter activity against the analog compound (Fig.  10D) . With this large increase in the white matter activity (characteristic degradation time of 120 min relative to the base case time of 9 days), the extent of cytotoxicity along the lamina I/II cut closest to the cannula tip decreased by only 28%. The primary peptidase activity controlling the spread of SP analogmediated toxicity into the laminae thus appears to be that of the gray matter.
Fourth, order-of-magnitude changes of base case laminar NK 1 R densities (B max ) significantly affected the expected cytotoxicity distribution in the spinal cord. Although these density parameters have been well measured by autoradiography for normal and altered lumbar spinal cord after chronic constriction injury of the sciatic nerve (1), other reports indicate that binding capacities may be a fewfold different at other spinal cord levels (10), during polyarthritis (27) , or after hindpaw inflammation or sciatic denervation (2) . Raising the receptor concentrations throughout the laminae is predicted to be similar in effect to a decrease of infusate concentration. Hence, a fivefold increase in NK 1 R would decrease the base case cytotoxic region by a degree similar to the 385 nM to 77 nM shift seen in Fig. 10A . On the other hand, a 10-fold decrease in NK 1 R density is sufficient to shift the cytotoxic contour from its baseline position to a location well inside the ventral horn, where motor neurons would be at risk (Fig. 10E) . During nociception, NK 1 R levels have been observed to increase approximately twofold (6, 30) . We have estimated that this would lead to an ϳ20% decrease in dorsal column penetration distance. In contrast, order-of-magnitude changes in the affinity constant [associated with peripheral inflammation or chronic constriction injury (1, 46) ] were calculated to have little effect on the extent of cytotoxicity due to tight binding and the existence of a sharp moving boundary at the leading edge of the region.
DISCUSSION
By direct infusion into the white matter dorsal column of the spinal cord, large-scale, controlled distribution of macromolecular drugs along the craniocaudal ). E: cytotoxic contours corresponding to decreasing NK1R density in gray matter from base case value (see Table 2 ) by a factor of 10 (385 nM SP-DTЈ and km-wm ϭ 0.000052 min
Ϫ1
). For A-E, SP-DTЈ was infused for 8 h at 0.1 l/min. length of the spinal cord can be achieved (26, 44, 54) . Corresponding transverse transport from the white matter into the adjacent gray matter is more limited. However, it may provide an ideal configuration for SP-DTЈ infusion because the target neurons within laminae I, II, and X are adjacent to the white matter interface, and SP-DTЈ must penetrate significant distances of interstitial gray matter before reaching NK 1 R-expressing anterior motor neurons. To characterize this proposed treatment protocol, a finite-element model of SP-DTЈ infusion was developed that combined mass transport, intracellular trafficking, and dose-response relations to predict the extent of transverse cytotoxicity in the spinal cord and assess whether the drug was delivered sufficiently well to kill the sensory neurons in the spinal cord that are responsible for the transmission of nociceptive signals.
For the base case simulation parameters, cytotoxic contours predict selective ablation of over one-half of the target neurons in laminae I and II at the level of the cannula tip after 8 h of 385 nM SP-DTЈ infusion at 0.1 l/min. Continually increasing regions of ablation of the target neurons were predicted with increasing infusate concentration. However, at the highest doses considered (770 nM), nonspecific binding, which is not accounted for in the present model, may occur, resulting in nonspecific damage (29, 52) . In previous rat studies by Wiley and Lappi (52) , intrastriatal injection of SP-saporin at high doses (ϳ570 nM) produced regions of central necrosis at the point of injection. Similar necrosis is expected with sufficiently high doses of diphtheria toxin.
In the gray matter, a slow SP interstitial degradation rate, consistent with the in vivo degradation rate of the analog DiMeC7 (14) , was considered. Such stabilized SP analog conjugates were predicted to penetrate target laminae ϳ60% farther than the penetration distances of more rapidly degraded native SP conjugates. Thus SP analogs stabilized against peptidase activity are expected to require a lower dose to be equally as effective as native SP conjugates. This is consistent with the observations of Wiley and Lappi (53) and Martin and Sloviter (29) , who reported that relatively low doses of the [Sar 9 ,Met(O 2 ) 11 ]-SP conjugate, injected into the rat striatum and hippocampus, achieved tissue ablation with negligible nonspecific damage. These findings highlight the limitations of native SP as a targeting moiety and underscore the need for a degradation-resistant SP analog that reduces the likelihood of nonspecific neuronal loss by lowering the administered dose requirement.
For the degradation-resistant SP analogs considered in our simulations, transverse gray matter penetration of SP-DTЈ was limited by the high binding affinity, i.e., the binding site barrier (21) . Evidence of this dynamic was the great sensitivity of cytotoxic spread to NK 1 R density in tissue. Thus cytotoxic spread may change according to the NK 1 R distribution, which may vary with spinal cord level (10) or source and duration of pain (2, 27) . Transverse cytotoxic spread was also sensitive to cannula placement. By moving the infusion site closer to the target lamina I/II, an asymmetric but more targeted ablation was achieved. Lateralized effects are desirable in all cases where nerve injury or damage affects only one limb. If bilateral treatment is required, the asymmetry in cytotoxic spread suggests that dual infusion from a symmetrically placed cannula adjacent to the corresponding lamina I/II may increase the ablation efficiency. However, care should be taken in cannula placement, inasmuch as more anterior cannula placement resulted in an increased likelihood of exposing motor neurons to the neurotoxin.
After the end of infusion, the SP-DTЈ remaining in the interstitial space continues to diffuse until it is bound/internalized or degraded by peptidase action. Thus transverse cytotoxic spread was predicted to extend beyond the contours calculated immediately after the end of infusion, at least for shorter infusion times (Ͻ6-8 h at 0.1 l/min base case). After longer infusions (Ͼ8 h), the remaining interstitial SP-DTЈ cannot penetrate beyond an effective transverse penetration limit, which is determined by the balance of binding and peptidase degradation. As a result, computational analysis of the postinfusional transverse cytotoxic spread may not be necessary after longer infusions.
To be as effective as surgical procedures currently used to alleviate chronic pain, the protein toxin must also spread in the craniocaudal direction to spinal cord regions that are contacted by ascending and descending branches of primary afferent nociceptive neurons (50) . Preliminary studies were conducted assessing the ability of the spinal cord model to predict interstitial transport of albumin in the craniocaudal direction. Simulation results corresponded to MRI measures for infusions up to ϳ25 l. This finding corresponds with a previous porous media model of CED in the rat spinal cord (44) , which shows a tendency to underestimate craniocaudal transport at larger infusion volumes. Both models predict loss of infusate solute into the adjacent CSF, suggesting that there may be an additional transport factor affecting the interstitial convective flow patterns. The pial membrane adherent to the exterior of the spinal cord may act as a fluid transport barrier, reducing the loss of fluid into the CSF. Alternatively, hydraulic conductivity may vary spatially within the white matter, with more localized deformation parallel to the white matter fibers near the infusion site. However, such transport effects are expected to have little effect on the convective flow patterns near the cannula tip and the present transverse transport analysis.
Craniocaudal cytotoxic distribution was calculated for a 25-l infusion of SP-DTЈ for a simplified case (assuming symmetry about the medial axis, i.e., the dorsal medial fissure, and central cannula placement, 2.1 mm posterior to lamina X). Simulations measuring the craniocaudal length along which there is cytotoxic penetration into lamina I/II predicted distances of 0.51, 1.36, and 1.43 cm corresponding to 10-, 20-, and 25-l infusions of 385 nM SP-DTЈ at 0.1 l/min (k m-wm ϭ 0.000052 min cytotoxic penetration into lamina I/II was predicted to increase by 34% over that immediately at the end of the infusion to a maximum distance of 1.9 cm. These results suggest that SP-DTЈ can achieve the rostrocaudal extent necessary for treatment of chronic pain conditions that extend over one or two spinal cord segments.
The hydraulic conductivity anisotropy ratio wm-z / wm-x , determined in a previous study (44) , allows prediction of the interstitial fluid flow patterns within the white matter of the spinal cord, provided infusion is limited to a volumetric flow regimen close to 0.1 l/min. At other flow rates, the anisotropy ratio and tissue porosity may diverge from the presented values because of tissue deformation effects. It is plausible, for example, that wm-z / wm-x and tissue porosity values may be considerably smaller in the situation of endogenous flows in normal white matter or, conversely, that these values may increase with increasing volumetric infusion rate and be associated with increased convective transport of SP-DTЈ.
In the determination of cytosol concentrations, uncertainty exists as to what fraction of the residence time in the sorting endosome is available for the transfer of protein toxin to the cytosol (e.g., because of changing pH or changes in budding efficiency during endosomic maturation). Delivery of the toxin to the cytosol is effectively determined by the factor k trans ϫ (time available for release to the cytosol). The k trans used in this study was not determined specifically for the SP-DTЈ, because its value has not been measured. We used the value for transferrin-diphtheria toxin determined by Yazdi and Murphy (57) , who determined that k trans depends heavily on the toxic moiety and is independent of the cell line involved. However, model simulations predict that there is no significant effect on the extent of cytotoxicity with nearly an order of magnitude uncertainty in k trans ϫ (time available for release to the cytosol), because the leading edge of the cytotoxic concentration profile of diphtheria toxin is so steep. However, there may be implications for other protein toxins. Hence, SP coupled to saporin or Pseudomonas exotoxin may have k trans values that differ greatly from that used for diphtheria toxin, resulting in different cytotoxic contours.
Interstitial infusion of SP-DTЈ directly into spinal cord tissue has not been undertaken in small or large animal models. Indeed, the results of the present study provide a guideline for future experiments. In particular, further experiments are needed to determine whether partial ablation of lamina I/II (ϳ60%) is sufficient to effectively treat chronic pain. Additional studies measuring white matter peptidase activity, nonspecific toxicity of SP-DTЈ, hydraulic conductivity at higher flow rates, and k trans would also be useful for further model development.
Given the complex nature of the tissue response to various infusion parameters, the computational model provides aid in assessing the design and implementation of specific therapeutic protocols. The present analysis predicts that direct infusion of SP-DTЈ can be used to selectively ablate NK 1 -expressing neurons in laminae I, II, and X and that anterior motor neurons are not at risk with careful consideration of cannula placement, infusate concentration, and flow rate. Findings applicable to future SP-DTЈ infusion designs are as follows: 1) Longer infusions did not necessarily translate into greater transverse spread into the regions exhibiting cytotoxic susceptibility. For the infusion conditions considered in this study, maximal laminar penetration was realized between ϳ6 and 8 h at 0.1 l/min (36-48 l). 2) High infusate concentrations provide maximal targeted ablation. However, nonspecific binding at very high concentrations should be avoided. 3) SP analogs designed to be resistant to enzymatic degradation are required, because naturally occurring SP degrades too rapidly. 4) Placement of the cannula adjacent to the target lamina I/II region provides for maximum laminar penetration of that side. However, care should be used in cannula placement, because more anteromedial placement may result in anterior motor neuron exposure. 5) Accurate measurement of NK 1 R density and peptidase activity in targeted spinal cord tissue is necessary, given the sensitivity of the cytotoxicity distribution to these parameters.
More generally, the type of model developed here for the spinal cord, with its inclusion of transport anisotropy, realistic anatomy, and pharmacodynamics, may now be extended to the description of drug delivery to other tissues of the CNS. Potential pharmacological agents with distribution that may be so predicted include the neurotrophic factors and excitotoxins for treatment of neurodegenerative disorders, enzymes for deficiency syndromes, genetic vectors, and radioimmunoconjugates for treatment or imaging.
